Arcutis Biotherapeutics (ARQT) Form 144 Filing on June 17

Arcutis Biotherapeutics (ARQT) filed Form 144 on June 17. This form indicates the intention to sell a specified number of shares in the public market. Such filings are typically done by insiders, including executives or major shareholders, and can signify potential selling pressure on the stock. Monitoring these filings is crucial as they can affect investor sentiment and trading activity surrounding the stock.